Harrow (HROW) Change in Intangibles (2023)

Harrow's (HROW) quarterly Change in Intangibles came in at $9000.0 in Q4 2023, up 100.05% quarter-over-quarter from -$19.6 million in Q3 2023.

Harrow (HROW) Change in Intangibles (2023) Analysis & Trends

Harrow's Change in Intangibles history runs 1 years deep, the most recent figure standing at $9000.0 for Q4 2023.

On a quarterly basis, Change in Intangibles changed N/A year-over-year to $9000.0 in Q4 2023; TTM through Dec 2023 was -$151.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$215000.0, up 99.42% from the prior year.
Change in Intangibles climbed to $9000.0 in Q4 2023 per HROW's latest filing, from -$19.6 million in the prior quarter.
Across five years, Change in Intangibles topped out at $9000.0 in Q4 2023 and bottomed at -$130.5 million in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Intangibles (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-107.94 Mn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Harrow	1.56 Bn	1.47 Bn	27.05 Mn	-

Download Data